Le diabète type 2 : actualités thérapeutiques
| dc.contributor.advisor | Zouhdi | |
| dc.contributor.author | Ahlam Ouali | |
| dc.date.accessioned | 2025-02-21T12:23:11Z | |
| dc.date.accessioned | 2025-12-17T10:01:21Z | |
| dc.date.available | 2025-02-21T12:23:11Z | |
| dc.date.issued | 2016 | |
| dc.description.collaborator | S. Makram | |
| dc.description.collaborator | Y. Sekhsokh | |
| dc.description.collaborator | N. Cherkaoui | |
| dc.description.collaborator | Y. Khabbal | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/36545 | |
| dc.language.iso | fr | |
| dc.publisher | Faculté de Médecine et de Pharmacie, Rabat - Thèse de médecine | fr_FR |
| dc.subject | Diabète type 2 | fr_FR |
| dc.subject | Ilots de Langerhans | fr_FR |
| dc.subject | Antidiabétique | fr_FR |
| dc.subject | Gliflozine | fr_FR |
| dc.subject | Actualité thérapeutique | fr_FR |
| dc.subject.ddc | 616 | |
| dc.subject.other | Pharmacie | |
| dc.subject.specific | Microbiologie | |
| dc.title | Le diabète type 2 : actualités thérapeutiques | fr_FR |
Files
Original bundle
1 - 1 of 1